These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25087409)

  • 1. [Investigation into the vestibular protective properties of melatoninergic agents].
    Iasnetsov VV; Motin VG; Karsanova SK; Iasnetsov VV; Ivanov IuV; Chel'naia NA
    Aviakosm Ekolog Med; 2014; 48(2):31-4. PubMed ID: 25087409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin MT
    López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.
    Juszczak M; Roszczyk M; Kowalczyk E; Stempniak B
    J Physiol Pharmacol; 2014 Dec; 65(6):777-84. PubMed ID: 25554981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in melatonin receptor expression in a murine model of glaucoma.
    Martínez-Águila A; Fonseca B; Pérez de Lara MJ; Miras-Portugal MT; Gómez-Villafuertes R; Carracedo G; Pintor J
    Mol Vis; 2020; 26():530-539. PubMed ID: 32818016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cetrorelix, a gonadotropin-releasing hormone antagonist, induces the expression of melatonin receptor 1a in the gonadotropin-releasing hormone neuronal cell line GT1-7.
    Ishii H; Sato S; Yin C; Sakuma Y; Kato M
    Neuroendocrinology; 2009; 90(3):251-9. PubMed ID: 19641296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of dual ligands for melatonin (MT1/MT2) and serotonin 5-HT2C receptor subtypes (II).
    Ettaoussi M; Pérès B; Errazani A; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
    Eur J Med Chem; 2015 Jan; 90():822-33. PubMed ID: 25528336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.
    Imbesi M; Uz T; Manev H
    Neuroscience; 2008 Sep; 155(4):1160-4. PubMed ID: 18664376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin-enhanced hyperactivation of hamster sperm.
    Fujinoki M
    Reproduction; 2008 Nov; 136(5):533-41. PubMed ID: 18715981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity.
    Barberino RS; Menezes VG; Ribeiro AEAS; Palheta RC; Jiang X; Smitz JEJ; Matos MHT
    Biol Reprod; 2017 Jun; 96(6):1244-1255. PubMed ID: 28595266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of agomelatine in a murine model of obsessive-compulsive disorder: interaction with meta-chlorophenylpiperazine, bicuculline, and diazepam.
    Bhutada P; Dixit P; Thakur K; Deshmukh P; Kaulaskar S
    Kaohsiung J Med Sci; 2013 Jul; 29(7):362-7. PubMed ID: 23768699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Melatonin Receptors Reduces Relapse-Like Alcohol Consumption.
    Vengeliene V; Noori HR; Spanagel R
    Neuropsychopharmacology; 2015 Dec; 40(13):2897-906. PubMed ID: 25994077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties.
    Guardiola-Lemaitre B; De Bodinat C; Delagrange P; Millan MJ; Munoz C; Mocaër E
    Br J Pharmacol; 2014 Aug; 171(15):3604-19. PubMed ID: 24724693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of melatonin receptor (MT1/2) promotes P-gp transporter in methamphetamine-induced toxicity on primary rat brain microvascular endothelial cells.
    Jumnongprakhon P; Sivasinprasasn S; Govitrapong P; Tocharus C; Tocharus J
    Toxicol In Vitro; 2017 Jun; 41():42-48. PubMed ID: 28223141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexually dimorphic modulation of GABA(A) receptor currents by melatonin in rat gonadotropin-releasing hormone neurons.
    Sato S; Yin C; Teramoto A; Sakuma Y; Kato M
    J Physiol Sci; 2008 Oct; 58(5):317-22. PubMed ID: 18834560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MT2 receptor stimulates axonogenesis and enhances synaptic transmission by activating Akt signaling.
    Liu D; Wei N; Man HY; Lu Y; Zhu LQ; Wang JZ
    Cell Death Differ; 2015 Apr; 22(4):583-96. PubMed ID: 25501601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microtubules modulate melatonin receptors involved in phase-shifting circadian activity rhythms: in vitro and in vivo evidence.
    Jarzynka MJ; Passey DK; Johnson DA; Konduru NV; Fitz NF; Radio NM; Rasenick M; Benloucif S; Melan MA; Witt-Enderby PA
    J Pineal Res; 2009 Mar; 46(2):161-71. PubMed ID: 19175856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin, selective and non-selective MT1/MT2 receptors agonists: differential effects on the 24-h vigilance states.
    Ochoa-Sanchez R; Comai S; Spadoni G; Bedini A; Tarzia G; Gobbi G
    Neurosci Lett; 2014 Feb; 561():156-61. PubMed ID: 24406151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT
    Legros C; Dupré C; Brasseur C; Bonnaud A; Bruno O; Valour D; Shabajee P; Giganti A; Nosjean O; Kenakin TP; Boutin JA
    Pharmacol Res Perspect; 2020 Feb; 8(1):e00539. PubMed ID: 31893123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New selective ligands of human cloned melatonin MT1 and MT2 receptors.
    Audinot V; Mailliet F; Lahaye-Brasseur C; Bonnaud A; Le Gall A; Amossé C; Dromaint S; Rodriguez M; Nagel N; Galizzi JP; Malpaux B; Guillaumet G; Lesieur D; Lefoulon F; Renard P; Delagrange P; Boutin JA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):553-61. PubMed ID: 12764576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant-like effects of agomelatine, melatonin and the NK1 receptor antagonist GR205171 in impulsive-related behaviour in rats.
    Loiseau F; Le Bihan C; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2005 Oct; 182(1):24-32. PubMed ID: 15986188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.